Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis

Patients with persistently elevated prostate specific antigen (PSA) and prior negative 12-core TRUS prostate biopsy (or biopsies) (systematic biopsy —SBx) are a diagnostic challenge. Repeat SBx or saturation biopsy in this cohort has been shown to have an even lower yield. The aim of our study is to compare the prostate cancer yield of magnetic resonance imaging (MRI) fusion biopsy (FBx) to SBx in a multi-institutional cohort comprised of pati ents with prior negative biopsies.

https://www.urologiconcology.org/article/S1078-1439(18)30124-8/fulltext?rss=yes

Source: Urologic Oncology: Seminars and Original Investigations - May 9, 2018 Category: Urology & Nephrology Authors: Abhinav Sidana, Matthew J. Watson, Arvin K. George, Ardeshir R. Rastinehad, Srinivas Vourganti, Soroush Rais-Bahrami, Akhil Muthigi, Mahir Maruf, Jennifer B. Gordetsky, Jeffrey W. Nix, Maria J. Merino, Baris Turkbey, Peter L. Choyke, Bradford J. Wood, Pet Tags: Original article Source Type: research